AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores a significant randomized controlled trial from 2024 assessing finerenone's effectiveness in heart failure patients with preserved ejection fraction. The hosts discuss the study's design, participant demographics, and key findings that demonstrate a reduction in worsening heart failure events and cardiovascular mortality compared to placebo.